Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10404355rdf:typepubmed:Citationlld:pubmed
pubmed-article:10404355lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C0018801lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C0018802lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C0216784lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C0026538lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C1516048lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:10404355lifeskim:mentionsumls-concept:C2699007lld:lifeskim
pubmed-article:10404355pubmed:issue2lld:pubmed
pubmed-article:10404355pubmed:dateCreated1999-9-14lld:pubmed
pubmed-article:10404355pubmed:abstractTextTo investigate the role of persistent angiotensin activity despite angiotensin-converting enzyme inhibitor therapy in the progression of heart failure, the Valsartan Heart Failure Trial has been designed to investigate the effect of the angiotensin-receptor blocker, valsartan, on morbidity and mortality.lld:pubmed
pubmed-article:10404355pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10404355pubmed:languageenglld:pubmed
pubmed-article:10404355pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10404355pubmed:citationSubsetIMlld:pubmed
pubmed-article:10404355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10404355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10404355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10404355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10404355pubmed:statusMEDLINElld:pubmed
pubmed-article:10404355pubmed:monthJunlld:pubmed
pubmed-article:10404355pubmed:issn1071-9164lld:pubmed
pubmed-article:10404355pubmed:authorpubmed-author:CohnJ NJNlld:pubmed
pubmed-article:10404355pubmed:authorpubmed-author:TognoniGGlld:pubmed
pubmed-article:10404355pubmed:authorpubmed-author:GlazerR DRDlld:pubmed
pubmed-article:10404355pubmed:authorpubmed-author:HesterAAlld:pubmed
pubmed-article:10404355pubmed:authorpubmed-author:SpormannDDlld:pubmed
pubmed-article:10404355pubmed:issnTypePrintlld:pubmed
pubmed-article:10404355pubmed:volume5lld:pubmed
pubmed-article:10404355pubmed:ownerNLMlld:pubmed
pubmed-article:10404355pubmed:authorsCompleteYlld:pubmed
pubmed-article:10404355pubmed:pagination155-60lld:pubmed
pubmed-article:10404355pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:meshHeadingpubmed-meshheading:10404355...lld:pubmed
pubmed-article:10404355pubmed:year1999lld:pubmed
pubmed-article:10404355pubmed:articleTitleRationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure.lld:pubmed
pubmed-article:10404355pubmed:affiliationDepartment of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.lld:pubmed
pubmed-article:10404355pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10404355pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10404355lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10404355lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10404355lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10404355lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10404355lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10404355lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10404355lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10404355lld:pubmed